Otrivin Duo (Xylometazoline Hydrochloride, Ipratropium Bromide)

Xylometazoline hydrochloride, the active ingredient in Otrivin Duo, is a nasal decongestant presented as a combination formulation for intranasal use. It relieves nasal congestion associated with colds, sinusitis and allergic rhinitis in adults and children. GNH USA supplies Otrivin Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivin Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin Duo combines Xylometazoline and Ipratropium to address nasal congestion pathways. It is indicated for: - Common cold: Reduces nasal blockage and improves airflow. - Acute sinusitis: Alleviates sinus pressure and congestion. - Allergic rhinitis: Decreases watery discharge and nasal stuffiness. - Post‑operative nasal care: Helps keep nasal passages clear after ENT procedures. - Seasonal allergy flare‑ups: Provides rapid relief of nasal obstruction.

Side effects are generally mild and related to local nasal irritation.

Common Side Effects: - Burning sensation: Mild burning or stinging at the application site. - Nasal dryness: Dryness or crust of the nasal mucosa. - Sneezing: Transient sneezing episodes after use. - Headache: Mild headache in some individuals. - Bitter taste: Unpleasant taste if the spray contacts the throat. - Mild epistaxis: Small amount of noseble .

Serious or Rare Side Effects: - Severe nasal irritation: Persistent pain or ulceration of the nasal lining. - Allergic reaction: Hives, swelling, or difficulty breathing. - Hypertensive crisis : Marked increase in blood pressure due to vasoconstriction.\n

When ​  ​  ​   ​    ...  ... ...  ...  … …  ... … … … … … … … … … …